Erlonat 150 mg (Erlotinib) Quantity:90 Tablet/s it enhances physiological erectile response

it enhances physiological erectile response when arousal occurs

and increase the interval between episodes of encephalopathy

Pregnancy and lactation – Vymada is contraindicated during pregnancy due to potential fetal toxicity

Sildalist 120mg provides unique physiological benefits due to the careful strategic synchronization of its dual active compounds

Shipping time typically 7–15 business days

Erlonat 150 mg (Erlotinib) Quantity:90 Tablet/s it enhances physiological erectile response\nErlonat 150 mg (Erlotinib) \nManufacturer: Natco Pharma Ltd. Strength: 150 mg Packaging: 30 tablets per bottle \n\nProduct Overview \nErlonat is an oral, targeted anticancer agent that contains the active pharmaceutical ingredient erlotinib. It is formulated as filmcoated tablets, each delivering 150 mg of the compound, and is supplied in a bottle containing 30 tablets. The product is indicated for the treatment of advanced nonsmall cell lung cancer